hydrazine antidepressants group nonselective irreversible monoamine oxidase inhibitors maois discovered initially marketed withdrawn due toxicity namely hepatotoxicity still remain clinical use tranylcypromine structurally unrelated maoi introduced around time hydrazines originally advertised nonhydrazine result diminished propensity causing hepatotoxicity legend withdrawn market partially discontinued bolded names indicate major drugs